Legend Biotech Corp. (LEGN) PT Lowered to $82 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Matthew Harrison lowered the price target on Legend Biotech Corp. (NASDAQ: LEGN) to $82.00 (from $85.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
